Photo of Charles (Charlie) Russell Taylor, MD

Charles (Charlie) Russell Taylor, MD

  • Director, Khosrow Momtaz Phototherapy Center
  • Director, Photosensitivity Clinic


Accepting New Patients

Request an appointment Refer a patient




Clinical Interests
  • Photodynamic therapy for actinic keratoses
  • Photosensitivity, phototesting
  • Photopatch testing
  • Polymorphic light eruption
  • Psoriasis
Medical Education
  • MD, University of Massachusetts Medical School
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Dermatology
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Based at MGH, Charles R. Taylor, MD is Associate Professor of Dermatology at Harvard Medical School. He is Director of the Khosrow Momtaz Phototherapy Center, where some 13,000 patients annually receive their outpatient ultraviolet treatments for chronic skin conditions.

Dr. Taylor is an active clinical consultant in all aspects of dermatology with special interests in skin cancer detection, and also in photodermatology, which encompasses the use of ultraviolet & visible light for all diagnostic & therapeutic purposes. He performs light testing and photopatch testing on light-sensitive individuals to determine which part of the action spectrum they are allergic to. Dr. Taylor has conducted laser surgery for the removal of unwanted tattoos and brown marks such as freckles and lentigines, and in fact, his clinical research led to the FDA approval of these now well established techniques. He has also performed laser surgery on vascular birthmarks and blood vessels.

Dr. Taylor has published extensively in the field of dermatology, and is a Fellow of the American Academy of Dermatology.

Edit Profile

Research & Publications

Research Summary
Dr. Taylor's interests lie in the area of enhancements to phototherapy and photochemotherapy protocols to best suit the needs of patients with psoriasis, atopic dermatitis, vitiligo, mycosis fungoides, and pruritus.

View my most recent publications at PubMed

Selected Reports:

  • Treatment of tattoos by Q-switched ruby laser. Arch Dermatol 1990; 126:893-9.
  • Light and electron microscopic analysis of tattoos treated by Q-switched ruby laser. J Invest Dermatol 1991; 97:131-6.
  • Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Inter J Dermatol 1993; 32:908-12.
  • Treatment of nevus of Ota by Q-switched ruby laser. J Amer Acad Dermatol 1994; 30:743-5.
  • Topical ALA-PDT for the treatment of acne vulgaris. J Invest Dermatol 2000; 115:183-92.
  • High-dose 308 nm excimer laser for the treatment of psoriasis. J Amer Acad Dermatol 2002; 46:732-7.
  • 308-nm excimer laser for the treatment of psoriasis. Arch Dermatol 2003; 139: 759-764.
  • PDT ALA HCL (Levulan?) 20% topical solution & visible blue light in the treatment of multiple actinic keratoses. Arch Dermatol 2004; 140:41-6.
  • A 308-nm excimer laser for the treatment of scalp psoriasis. Lasers Surg Med 2004; 34: 136-140.
  • Ultraviolet light induces the damage-responsive transcription factor. J Invest Dermatol 2005; 125: 323-333.
  • UVA-1 Phototherapy for Cutaneous Diseases. Photodermatol Photoimmunol Photochem 2006; 22: 247-253.
  • In vivo singlet oxygen dosimetry of 5-aminolevulinic acid PDT in normal human subjects. Journal of Biomedical Optics 2008; 13(5):1-3.

Edit Profile


Dermatology Associates
50 Staniford Street
2nd Floor
Boston MA, 02114-2517
Phone: 617-726-2914
Fax: 617-726-7768

Edit Profile

Back to Top